Silent plight
Our Medical Director Tim Jobson was recently featured in Pharma Times talking about why a new approach is needed for primary biliary cholangitis trials.
Read the full article here: https://pharmatimes.com/web_exclusives/silent-plight/
Our Medical Director Tim Jobson was recently featured in Pharma Times talking about why a new approach is needed for primary biliary cholangitis trials.
Read the full article here: https://pharmatimes.com/web_exclusives/silent-plight/
When Jane received a letter about her liver health, she admits she was surprised – but pleasantly so. Living in rural Somerset and working 30
When the letter from the NHS dropped through my door, I’ll be honest – I didn’t panic. These days, my wife and I joke that
Somerset, UK, 18th March 2026: Predictive Health Intelligence (PHI) and Sano Genetics today announced the completion of recruitment into the LiveWell study, with 996 participants